Preferred Label : desonide;
MeSH definition : A nonfluorinated corticosteroid anti-inflammatory agent used topically for DERMATOSES.;
MeSH synonym : prednacinolone;
CISMeF synonym : CS brand of desonide; pierre fabre brand of desonide; Clay-Park brand of desonide; clay park brand of desonide; bayer brand of desonide; owen brand of desonide; galderma brand of desonide; alcon brand of desonide;
DeCS synonym : Trid sonit;
MeSH hyponym : desone; tridesilon; tridésonit; desowen; locapred; Locatop; Desocort;
MeSH CAS label : Pregna-1,4-diene-3,20-dione, 11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-,
(11beta,16alpha)-;
MeSH Related Number : 638-94-8 (Desonide);
Registry Number MeSH : 638-94-8;
MeSH annotation : D25-26 qualif;
Wikipedia link : https://en.wikipedia.org/wiki/Desonide;
Codes EINECS : 211-351-6;
Is substance : O;
UNII : J280872D1O;
InChIKey : WBGKWQHBNHJJPZ-LECWWXJVSA-N;
Origin ID : D003898;
UMLS CUI : C0011705;
ATC code(s)
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
Fils d'après SNOMED CT
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A nonfluorinated corticosteroid anti-inflammatory agent used topically for DERMATOSES.
https://www.has-sante.fr/portail/jcms/c_2899630/fr/tridesonit
2019
false
France
French
corticosteroid therapy
evaluation of the transparency committee
administration, cutaneous
insurance, health, reimbursement
desonide
desonide
anti-inflammatory agents
dermatitis, contact
dermatitis, atopic
dermatitis
venous insufficiency
psoriasis
dermatitis, seborrheic
prurigo
insect bites and stings
treatment outcome
skin diseases, parasitic
stasis dermatitis, nos
---
https://www.has-sante.fr/portail/jcms/c_2887756/fr/locatop-locapred
2018
false
false
false
France
desonide
insurance, health, reimbursement
treatment outcome
anti-inflammatory agents
administration, cutaneous
desonide
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1649701/fr/locatop-locapred
http://www.has-sante.fr/portail/jcms/c_732193/locapred-locatop
2013
France
French
corticosteroid therapy
evaluation of the transparency committee
desonide
administration, cutaneous
insurance, health, reimbursement
anti-inflammatory agents
desonide
dermatitis, contact
dermatitis, atopic
lichenoid eruptions
psoriasis
stasis dermatitis, nos
dermatitis, seborrheic
insect bites and stings
prurigo
granuloma annulare
pustulosis of palms and soles
pruritus
mycosis fungoides
eczema
venous insufficiency
---
http://www.has-sante.fr/portail/jcms/c_1649707/fr/tridesonit
http://www.has-sante.fr/portail/jcms/c_725771/tridesonit
http://www.has-sante.fr/portail/jcms/c_1649706/fr/tridesonit-18092013-avis-ct13020
2013
France
French
corticosteroid therapy
evaluation of the transparency committee
administration, cutaneous
insurance, health, reimbursement
desonide
desonide
anti-inflammatory agents
dermatitis, contact
dermatitis, atopic
dermatitis
venous insufficiency
psoriasis
dermatitis, seborrheic
prurigo
insect bites and stings
treatment outcome
skin diseases, parasitic
stasis dermatitis, nos
---
http://www.lecrat.eu/?s=D%C3%A9sonide
2009
France
French
corticosteroid therapy
breast feeding
pregnancy
anti-inflammatory agents
desonide
desonide
drug information
---
http://www.has-sante.fr/portail/display.jsp?id=c_437499
2006
France
French
corticosteroid therapy
suppositories
administration, rectal
corticosteroids
drug combinations
alpha-Tocopherol
lidocaine
retinol palmitate
vitamin A
heparin
ruscus
glucosides
desonide
hemorrhoids
anti-inflammatory agents
anesthetics, local
treatment outcome
evaluation of the transparency committee
---